Literature DB >> 12435746

Recruitment of heterogeneous nuclear ribonucleoprotein A1 in vivo to the LMP/TAP region of the major histocompatibility complex.

Rossen Donev1, Roger Horton, Stephan Beck, Teodora Doneva, Radost Vatcheva, W Richard Bowen, Denise Sheer.   

Abstract

Sequences containing the matrix recognition signature were identified adjacent to the LMP/TAP gene cluster in the human and mouse major histocompatibility complex class II region. These sequences were shown to function as nuclear matrix attachment regions (MARs). Three of the five human MARs and the single mouse MAR recruit heterogeneous nuclear ribonucleoprotein A1 (hnRNP-A1) in vivo during transcriptional up-regulation of the major histocompatibility complex class II genes. The timing of this recruitment correlates with a rise in mature TAP1 mRNA. Two of the human MARs bind hnRNP-A1 in vitro directly within a 35-bp sequence that shows over 90% similarity to certain Alu repeat sequences. This study shows that MARs recruit and bind hnRNP-A1 upon transcriptional up-regulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435746     DOI: 10.1074/jbc.M206621200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Specific interaction of heterogeneous nuclear ribonucleoprotein A1 with the -219T allelic form modulates APOE promoter activity.

Authors:  Mónica Campillos; José Ramón Lamas; Miguel Angel García; María Jesús Bullido; Fernando Valdivieso; Jesús Vázquez
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

2.  A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoforms.

Authors:  R Donev; A Newall; J Thome; D Sheer
Journal:  Mol Psychiatry       Date:  2007-03-13       Impact factor: 15.992

3.  High-level transgene expression by homologous recombination-mediated gene transfer.

Authors:  Mélanie Grandjean; Pierre-Alain Girod; David Calabrese; Kaja Kostyrko; Marianne Wicht; Florence Yerly; Christian Mazza; Jacques S Beckmann; Danielle Martinet; Nicolas Mermod
Journal:  Nucleic Acids Res       Date:  2011-06-07       Impact factor: 16.971

4.  A comparative study of S/MAR prediction tools.

Authors:  Kenneth Evans; Sascha Ott; Annika Hansen; Georgy Koentges; Lorenz Wernisch
Journal:  BMC Bioinformatics       Date:  2007-03-02       Impact factor: 3.169

5.  Matrix association region/scaffold attachment region (MAR/SAR) sequence: its vital role in mediating chromosome breakages in nasopharyngeal epithelial cells via oxidative stress-induced apoptosis.

Authors:  Sang-Nee Tan; Sai-Peng Sim; Alan S B Khoo
Journal:  BMC Mol Biol       Date:  2018-12-04       Impact factor: 2.946

6.  Interplay between REST and nucleolin transcription factors: a key mechanism in the overexpression of genes upon increased phosphorylation.

Authors:  Teeo Tediose; Martin Kolev; Baalasubramanian Sivasankar; Paul Brennan; B Paul Morgan; Rossen Donev
Journal:  Nucleic Acids Res       Date:  2010-01-25       Impact factor: 16.971

7.  Modulation of CD59 expression by restrictive silencer factor-derived peptides in cancer immunotherapy for neuroblastoma.

Authors:  Rossen M Donev; Lisa C Gray; Baalasubramanian Sivasankar; Timothy R Hughes; Carmen W van den Berg; B Paul Morgan
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

8.  Association of the matrix attachment region recognition signature with coding regions in Caenorhabditis elegans.

Authors:  Alasdair Anthony; Mark Blaxter
Journal:  BMC Genomics       Date:  2007-11-15       Impact factor: 3.969

9.  Genetic control of the innate immune response.

Authors:  Christine A Wells; Timothy Ravasi; Geoffrey J Faulkner; Piero Carninci; Yasushi Okazaki; Yoshihide Hayashizaki; Matthew Sweet; Brandon J Wainwright; David A Hume
Journal:  BMC Immunol       Date:  2003-06-26       Impact factor: 3.615

Review 10.  Anchoring the genome.

Authors:  Diego Ottaviani; Elliott Lever; Petros Takousis; Denise Sheer
Journal:  Genome Biol       Date:  2008-01-22       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.